Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00214149 · ClinicalTrials.gov registry record · Phase 2
Multi-catheter High Dose Rate (HDR) Breast Brachytherapy
A Phase 2 study, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- Phase 2
- Development phase
- 127
- Enrollment target
NCT00214149 is a Phase 2 study that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 127 participants.
The verdict
NCT00214149, a Phase 2 study, was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 127 participants
- Enrollment target
Study Summary
Breast conservation therapy (BCT) is now widely accepted as a treatment option for most women with Stage I and II invasive breast cancer and most patients with ductal carcinoma in situ (DCIS). Despite superior cosmetic outcome, BCT is more complex and requires a protracted treatment regimen comprised of 6 weeks of daily external beam radiation therapy to the whole breast. The purpose of this study is to determine if an acceptable outcome can be achieved with radiation delivered only to the region of the tumor bed. If this is true, partial breast irradiation may lend itself to much shorter treatment times (one week) and the toxicities to adjacent normal structures (heart, lung, chest wall) will be greatly reduced.
Interventions
- RADIATION brachytherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2004-10 |
| Est. Completion | 2010-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00214149
The ClinicalTrials.gov registry entry for NCT00214149 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 127 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which brachytherapy is the first listed.
NCT00214149 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00214149 about?
NCT00214149 is a clinical study titled "Multi-catheter High Dose Rate (HDR) Breast Brachytherapy". Breast conservation therapy (BCT) is now widely accepted as a treatment option for most women with Stage I and II invasive breast cancer and most patients with ductal carcinoma in situ (DCIS). Despite superior cosmetic outcome, BCT is more complex and requires a protracted treatment regimen comprise...
What is the current status of trial NCT00214149?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 127 participants. The study started on 2004-10. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00214149?
The interventions under investigation include: brachytherapy (RADIATION).
Who is sponsoring clinical trial NCT00214149?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.